Leerink Partnrs Reduces Earnings Estimates for Enhabit

Enhabit, Inc. (NYSE:EHAB) – Research analysts at Leerink Partnrs decreased their FY2024 earnings estimates for shares of Enhabit in a research note issued on Monday, November 18th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.24 for the year, down from their prior forecast of $0.27. The consensus estimate for Enhabit’s current full-year earnings is $0.25 per share. Leerink Partnrs also issued estimates for Enhabit’s Q4 2024 earnings at $0.07 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at $0.03 EPS, FY2025 earnings at $0.23 EPS, FY2026 earnings at $0.27 EPS and FY2027 earnings at $0.15 EPS.

Separately, Leerink Partners reiterated a “market perform” rating and set a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research report on Tuesday. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $9.25.

Enhabit Price Performance

EHAB stock opened at $7.41 on Thursday. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm’s 50-day moving average price is $7.52 and its two-hundred day moving average price is $8.42. The stock has a market capitalization of $372.69 million, a price-to-earnings ratio of -3.19 and a beta of 1.84.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter in the previous year, the firm posted $0.03 EPS.

Institutional Investors Weigh In On Enhabit

Hedge funds have recently bought and sold shares of the business. FMR LLC boosted its stake in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Gladius Capital Management LP bought a new stake in Enhabit during the second quarter worth about $31,000. Quarry LP boosted its stake in Enhabit by 242.2% during the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares in the last quarter. ProShare Advisors LLC bought a new stake in Enhabit during the first quarter worth about $118,000. Finally, Stoneridge Investment Partners LLC bought a new position in shares of Enhabit in the third quarter worth approximately $81,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.